TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 MARKET SYNOPSIS 15
2 MARKET INTRODUCTION
2.1 DEFINITION 17
2.2 SCOPE OF THE STUDY 17
2.3 RESEARCH OBJECTIVE 17
2.4 MARKET STRUCTURE 18
2.5 ASSUMPTIONS & LIMITATIONS 18
3 RESEARCH METHODOLOGY
4 MARKET DYNAMICS
4.1 OVERVIEW 28
4.2 DRIVERS 29
4.2.1 HIGH DEMAND FOR LIPOSUCTION, HAIR TRANSPLANTATION, AND THE RISING OBESE AND GERIATRIC POPULATION 29
4.2.2 GROWING EXPENDITURE ON COSMETIC SURGERIES 29
4.2.3 PREVALENCE OF SKIN DISEASES 30
4.2.4 TECHNOLOGICAL ADVANCEMENTS IN THE AESTHETIC INDUSTRY 30
4.2.5 INCREASING ACCEPTANCE OF FACIAL AESTHETICS 30
4.3 RESTRAINTS 31
4.3.1 HIGH PROCEDURAL COSTS 31
4.3.2 LACK OF TRAINING FOR AESTHETIC PROCEDURES 31
4.3.3 SIDE-EFFECTS ASSOCIATED WITH AESTHETICS PROCEDURES 32
4.4 OPPORTUNITIES 33
4.4.1 RISING DEMAND FOR MINIMALLY INVASIVE PROCEDURES 33
5 MARKET FACTOR ANALYSIS
5.1 PORTER'S FIVE FORCES MODEL 34
5.1.1 BARGAINING POWER OF SUPPLIERS 35
5.1.2 BARGAINING POWER OF BUYERS 35
5.1.3 THREAT OF NEW ENTRANTS 35
5.1.4 THREAT OF SUBSTITUTES 35
5.1.5 INTENSITY OF RIVALRY 35
5.2 VALUE CHAIN ANALYSIS 36
5.2.1 RESEARCH & DEVELOPMENT 37
5.2.2 MANUFACTURING 37
5.2.3 DISTRIBUTION 37
5.2.4 MARKETING & SALES 37
5.2.5 POST-SALES MONITORING 37
5.3 INVESTMENT OPPORTUNITIES 38
5.4 PRICE ANALYSIS 38
6 GLOBAL MEDICAL AESTHETICS MARKET, BY PRODUCT
6.1 OVERVIEW 39
6.2 FACIAL AESTHETIC 41
6.2.1 BOTULINUM TOXIN 41
6.2.2 DERMAL FILLERS 42
6.2.3 MICRODERMABRASION DEVICES 42
6.2.4 OTHERS 43
6.3 BODY CONTOURING DEVICES 43
6.3.1 NONSURGICAL FAT REDUCTION DEVICES 44
6.3.2 CELLULITE REDUCTION DEVICES 45
6.3.3 LIPOSUCTION DEVICES 45
6.4 COSMETIC IMPLANTS 46
6.4.1 BREAST IMPLANTS 47
6.4.2 FACIAL IMPLANTS 47
6.4.3 OTHERS 47
6.5 HAIR REMOVAL DEVICES 48
6.6 SKIN AESTHETIC DEVICES 48
6.6.1 LASER SKIN RESURFACING DEVICES 49
6.6.2 NONSURGICAL SKIN TIGHTENING DEVICES 50
6.6.3 MICRO-NEEDLING PRODUCTS 50
6.6.4 LIGHT THERAPY DEVICE 51
6.7 TATTOO REMOVAL DEVICES 51
6.8 OTHERS 52
7 GLOBAL MEDICAL AESTHETICS MARKET, BY END USER
7.1 OVERVIEW 53
7.2 HOSPITALS & CLINICS 54
7.3 DERMATOLOGY & COSMETIC CENTERS 54
7.4 OTHERS 55
8 GLOBAL MEDICAL AESTHETICS MARKET, BY REGION
8.1 OVERVIEW 56
8.2 AMERICAS 58
8.2.1 NORTH AMERICA 60
8.2.2 LATIN AMERICA 68
8.3 EUROPE 71
8.3.1 GERMANY 74
8.3.2 FRANCE 77
8.3.3 UK 79
8.3.4 ITALY 82
8.3.5 SPAIN 84
8.3.6 IRELAND 87
8.3.7 REST OF EUROPE 89
8.4 ASIA-PACIFIC 92
8.4.1 CHINA 95
8.4.2 JAPAN 98
8.4.3 SOUTH KOREA 100
8.4.4 INDIA 103
8.4.5 AUSTRALIA 105
8.4.6 REST OF ASIA-PACIFIC 108
8.5 MIDDLE EAST & AFRICA 111
8.5.1 MIDDLE EAST 114
8.5.2 AFRICA 116
10 COMPETITIVE LANDSCAPE
9.1 INTRODUCTION 119
9.2 COMPETITIVE BENCHMARKING 120
9.3 KEY DEVELOPMENTS 121
11 COMPANY PROFILES
10.1 ALLERGAN 123
10.1.1 COMPANY OVERVIEW 123
10.1.2 FINANCIAL OVERVIEW 123
10.1.3 PRODUCTS/SERVICES OFFERED 124
10.1.4 ALLERGAN: KEY DEVELOPMENTS 124
10.1.5 SWOT ANALYSIS 125
10.1.6 KEY STRATEGIES 125
10.2 MERZ PHARMA GMBH & CO. KGAA 126
10.2.1 COMPANY OVERVIEW 126
10.2.2 FINANCIAL OVERVIEW 126
10.2.3 PRODUCTS/SERVICES OFFERED 127
10.2.4 KEY DEVELOPMENTS 127
10.2.5 SWOT ANALYSIS 128
10.2.6 KEY STRATEGIES 128
10.3 LUMENIS 129
10.3.1 COMPANY OVERVIEW 129
10.3.2 FINANCIAL OVERVIEW 129
10.3.3 PRODUCTS/SERVICES OFFERED 129
10.3.4 KEY DEVELOPMENTS 130
10.3.5 SWOT ANALYSIS 130
10.3.6 KEY STRATEGIES 130
10.4 HOLOGIC INC. 131
10.4.1 COMPANY OVERVIEW 131
10.4.2 FINANCIAL OVERVIEW 131
10.4.3 PRODUCTS/SERVICES OFFERED 132
10.4.4 KEY DEVELOPMENTS 132
10.4.5 SWOT ANALYSIS 133
10.4.6 KEY STRATEGIES 133
10.5 GALDERMA SA 134
10.5.1 COMPANY OVERVIEW 134
10.5.2 FINANCIAL OVERVIEW 134
10.5.3 PRODUCTS/SERVICES OFFERED 135
10.5.4 KEY DEVELOPMENTS 135
10.5.5 SWOT ANALYSIS 135
10.5.6 KEY STRATEGIES 136
10.6 BAUSCH HEALTH (VALEANT PHARMACEUTICALS) 137
10.6.1 COMPANY OVERVIEW 137
10.6.2 FINANCIAL OVERVIEW 137
10.6.3 PRODUCTS/SERVICES OFFERED 138
10.6.4 KEY DEVELOPMENTS 138
10.6.5 SWOT ANALYSIS 138
10.6.6 KEY STRATEGIES 139
10.7 ANIKA THERAPEUTICS INC. 140
10.7.1 COMPANY OVERVIEW 140
10.7.2 FINANCIAL OVERVIEW 140
10.7.3 PRODUCTS/SERVICES OFFERED 141
10.7.4 KEY DEVELOPMENTS 141
10.7.5 SWOT ANALYSIS 141
10.7.6 KEY STRATEGIES 141
10.8 CUTERA 142
10.8.1 COMPANY OVERVIEW 142
10.8.2 FINANCIAL OVERVIEW 142
10.8.3 PRODUCTS/SERVICES OFFERED 143
10.8.4 KEY DEVELOPMENTS 143
10.8.5 SWOT ANALYSIS 144
10.8.6 KEY STRATEGIES 144
10.9 ALMA LASERS 145
10.9.1 COMPANY OVERVIEW 145
10.9.2 FINANCIAL OVERVIEW 145
10.9.3 PRODUCTS/SERVICES OFFERED 146
10.9.4 KEY DEVELOPMENTS 146
10.9.5 SWOT ANALYSIS 147
10.9.6 KEY STRATEGIES 147
10.10 SYNERON MEDICAL LTD 148
10.10.1 COMPANY OVERVIEW 148
10.10.2 FINANCIAL OVERVIEW 148
10.10.3 PRODUCTS/SERVICES OFFERED 148
10.10.4 KEY DEVELOPMENTS 148
10.10.5 SWOT ANALYSIS 149
10.10.6 KEY STRATEGIES 149
12 APPENDIX
11.1 REFERENCES 150
11.2 RELATED REPORTS 151
